Close Menu

NEW YORK (GenomeWeb) – With new installations and rapidly growing revenues, Somalogic's SOMAscan platform is becoming a significant player in the protein biomarker discovery service space.

According to Somalogic CEO Byron Hewett, the platform is on pace to generate more than $20 million in revenue this year, roughly doubling the $10.5 million in revenue the platform notched in 2013. Hewett added that by the end of 2015 the company expects to have installed systems in between 20 and 30 core laboratories.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.